Skip to main content
Amplitude Surgical logo

Amplitude Surgical — Investor Relations & Filings

Ticker · AMPLI ISIN · FR0012789667 LEI · 9695006Q1VL1OHK06336 PA Manufacturing
Open in API
Filings indexed 269 across all filing types
Latest filing 2025-07-29 Regulatory Filings
Country FR France
Listing PA AMPLI

About Amplitude Surgical

https://www.amplitude-surgical.com/en/

Amplitude Surgical is a company specializing in the design, manufacture, and marketing of surgical technologies for lower-limb orthopedics. Its primary focus is on developing high-end implants and prostheses for hip and knee replacement surgeries. The company provides a range of products, including femoral stems, acetabular cups, and total knee prostheses, along with associated instrumentation. Amplitude Surgical supports surgeons and healthcare facilities through a global distribution network composed of direct subsidiaries and exclusive distributors, aiming to restore mobility for patients through innovative orthopedic solutions.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a short press release (1882 characters) announcing the suspension of the company's stock trading on Euronext Paris. It does not contain financial statements, board changes, or other specific report types, but rather serves as a regulatory notification regarding market activity. As it does not fit into specific categories like 'Delisting' (which implies a permanent removal) or 'M&A', it falls under the general regulatory announcement category.
2025-07-29 French
Inside Information / Other news releases
Delisting Announcement Classification · 100% confidence The document is a short press release (1673 characters) announcing the suspension of the company's share listing on the Euronext market. It does not contain financial statements, proxy materials, or other detailed reports, but rather serves as an official notice of a market-related event. Since it specifically concerns the suspension of trading, it fits the definition of a delisting or trading suspension announcement, which falls under the 'DLST' category.
2025-07-29 English
Inside Information / Information on annual revenues
Earnings Release Classification · 100% confidence The document is a press release from Amplitude Surgical announcing its consolidated revenue for the 2024-25 fiscal year. It provides key financial highlights, growth percentages, and a brief outlook on EBITDA margins. It is under 5,000 characters and serves as an initial announcement of financial results rather than the full audited annual report (which is scheduled for release in October). Therefore, it fits the definition of an Earnings Release. FY 2025
2025-07-24 English
Informations privilégiées / Information sur chiffre d’affaires annuel
Earnings Release Classification · 100% confidence The document is a press release from Amplitude Surgical announcing its annual consolidated revenue for the fiscal year 2024-25. It provides key financial highlights, revenue breakdowns by region, and a preliminary EBITDA margin estimate. It is not the full annual report (10-K) but rather the initial announcement of financial results, which fits the definition of an Earnings Release (ER). FY 2025
2025-07-24 French
Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité
Transaction in Own Shares Classification · 95% confidence The document is a 'Bilan semestriel du contrat de liquidité' (Half-year liquidity contract report) for Amplitude Surgical. This type of filing details the transactions made by a liquidity provider on behalf of the company to maintain share liquidity. In many jurisdictions, including France, these are standard regulatory disclosures regarding share buybacks and market-making activities. Since the document reports on the company's own share transactions (buybacks/sales) conducted under a liquidity contract, it falls under the 'Transaction in Own Shares' category.
2025-07-21 French
Informations privilégiées / Autres communiqués
M&A Activity Classification · 98% confidence The document is a press release dated April 25, 2025, announcing that Zydus Lifesciences Limited has signed an acquisition agreement to acquire a majority stake in Amplitude Surgical SA from PAI Partners and other shareholders. It details the terms of the acquisition block (85.6% stake) and mentions future steps, including a mandatory simplified public tender offer to the AMF (Autorité des marchés financiers) followed by a squeeze-out. This clearly relates to a significant corporate transaction involving a change in control and capital structure. This falls under the category of M&A Activity (TAR). It is not a full financial report (10-K or IR), an earnings release (ER), or a general regulatory filing (RNS), but a specific announcement about a takeover/merger proposal.
2025-04-25 French

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.